Activation receptor-induced tolerance of mature NK cells in vivo requires signaling through the receptor and is reversible.
NK cell responses are determined by signals received through activating and inhibitory cell surface receptors. Ly49H is an NK cell-specific activating receptor that accounts for the genetic resistance to murine CMV (MCMV). The Ly49H receptor has been shown to interact with two adaptor proteins (DAP12 and DAP10). In the context of MCMV infection, interaction of m157 (the MCMV-encoded ligand for Ly49H) with Ly49H results in activation of Ly49H-expressing NK cells. Chronic exposure of Ly49H with m157, however, induces tolerance in these same cells. The mechanism of this tolerance remains poorly understood. Using a transgenic mouse model, we demonstrate that induction of tolerance in Ly49H(+) NK cells by chronic exposure to m157, in vivo, requires signaling through the Ly49H adaptor protein DAP12, but not the DAP10 adaptor protein. Furthermore, mature Ly49H-expressing NK cells from wild-type mice can acquire a tolerant phenotype by 24 h posttransfer into a transgenic C57BL/6 mouse that expresses m157. The tolerant phenotype can be reversed, in vivo, if tolerant NK cells are transferred to mice that do not express the m157 protein. Thus, continuous activating receptor engagement can induce a transient tolerance in mature NK cells in vivo. These observations provide new insight into how activating receptor engagement shapes NK cell function and has important implications in how NK cells respond to tumors and during chronic viral infection.
Gastroenterology Division, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.
Fred D
FD
Bolanos
Sandeep K
SK
Tripathy
D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics / Q000378:metabolism; D019264:Adoptive Transfer; D000595:Amino Acid Sequence; D000818:Animals; D002454:Cell Differentiation / Q000235:genetics / Q000276:immunology*; D002478:Cells, Cultured; D055879:Gene Knock-In Techniques; D007108:Immune Tolerance / Q000235:genetics; D008024:Ligands; D008213:Lymphocyte Activation / Q000235:genetics / Q000276:immunology; D008565:Membrane Proteins / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D018146:Muromegalovirus / Q000276:immunology*; D055650:NK Cell Lectin-Like Receptor Subfamily A / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*; D034521:Nuclear Matrix-Associated Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D029543:Nucleocytoplasmic Transport Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D011971:Receptors, Immunologic / Q000172:deficiency / Q000235:genetics / Q000378:metabolism / Q000502:physiology*
D048868:Adaptor Proteins, Signal Transducing; C120528:HCST protein, human; C492355:Hcst protein, mouse; C527096:Klra8 protein, mouse; D008024:Ligands; D008565:Membrane Proteins; D055650:NK Cell Lectin-Like Receptor Subfamily A; D034521:Nuclear Matrix-Associated Proteins; D029543:Nucleocytoplasmic Transport Proteins; C490521:Rae1 protein, mouse; D011971:Receptors, Immunologic; C110546:TYROBP protein, human; C484963:Tyrobp protein, mouse
Nat Immunol. 2008 May;9(5):495-502
18425106
J Exp Med. 2010 Sep 27;207(10):2065-72
20819928
Eur J Immunol. 2009 Apr;39(4):1129-35
19247984
Science. 2001 May 4;292(5518):934-7
11340207
Immunogenetics. 2008 Oct;60(10):565-73
18668236
Nat Immunol. 2002 Dec;3(12):1150-5
12426564
Nat Immunol. 2005 Sep;6(9):928-37
16116470
J Immunol. 2006 Jun 1;176(11):6615-23
16709819
Eur J Immunol. 2003 Sep;33(9):2410-8
12938217
Blood. 2005 Sep 1;106(5):1711-7
15886320
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8826-31
12060703
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1915-9
19181844
J Exp Med. 2010 Sep 27;207(10):2073-9
20819924
Nature. 2001 Sep 13;413(6852):165-71
11557981
Nat Immunol. 2001 Oct;2(10):951-6
11550009
J Virol. 2006 Jan;80(1):545-50
16352579
Blood. 2008 Apr 1;111(7):3571-8
18198346
Curr Opin Immunol. 2005 Oct;17(5):505-9
16087327
Nature. 2005 Aug 4;436(7051):709-13
16079848
Blood. 2007 Jan 1;109(1):323-30
16940427
Nat Immunol. 2006 May;7(5):517-23
16565719
Nat Immunol. 2000 Aug;1(2):119-26
11248803
Sci STKE. 2001 Mar 27;2001(75):re1
11752646
Blood. 2004 Jan 15;103(2):664-72
14504081
Semin Cancer Biol. 2006 Oct;16(5):333-43
16914326
Semin Cancer Biol. 2006 Oct;16(5):359-66
16904340
J Immunol. 2005 Jul 15;175(2):720-9
16002667
J Exp Med. 2009 Apr 13;206(4):807-17
19332875
Immunity. 2000 Jun;12(6):721-7
10894171
J Exp Med. 2008 Aug 4;205(8):1829-41
18606857
J Immunol. 2005 Nov 1;175(9):5790-8
16237071
Immunity. 2000 Sep;13(3):355-64
11021533
Nature. 2009 Jan 29;457(7229):557-61
19136945
Science. 2002 May 17;296(5571):1323-6
11950999
Curr HIV Res. 2008 Sep;6(5):433-40
18855653
J Immunol. 2008 Jul 1;181(1):265-75
18566392
J Immunol. 2010 Jul 1;185(1):157-65
20530257
Blood. 2010 Feb 11;115(6):1166-74
19903900
Immunol Rev. 2006 Dec;214:118-29
17100880
J Exp Med. 2008 Aug 4;205(8):1819-28
18606858